David E. Yocum

8.1k citations
89 papers · 4.8k indexed · 1 hit paper · h-index 33

Impact in

  • Rheumatology top 0.2%
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
  • Ophthalmology top 0.5%
    • Ocular Diseases and Behçet’s Syndrome
    • Retinal and Optic Conditions

Papers in

    • Rheumatoid Arthritis Research and Therapies 41
    • Systemic Lupus Erythematosus Research 22
    • T-cell and B-cell Immunology 17
    • Immune Cell Function and Interaction 7
    • Toxin Mechanisms and Immunotoxins 6

David E. Yocum

89 papers receiving 4.6k citations

Hit Papers

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel 2000 · 722 citations
7222000202620082017200400600

Peers

David E. Yocum
Comparison fields: 5 of 126
  • Rheumatology 2.4k
  • Ophthalmology 758
  • Hematology 790
  • Immunology 1.3k
  • Genetics 399
Replace C M Lockwood with:
C M Lockwood United Kingdom
Jeffrey Siegel United States
Timothy R. D. J. Radstake Netherlands
Raphaela Goldbach‐Mansky United States
Gunnar Sturfelt Sweden
Roberto Gerli Italy
D. Sène France
Salvatore Albani United States
David Tak Yan Yu United States
Diego Kyburz Switzerland
David E. Yocum relative to C M Lockwood United Kingdom C M Lockwood's profile →
Citations per field
00.5×4.5×
C M Lockwood · 1×
Citations per year

Countries citing papers authored by David E. Yocum

Since Specialization
Citations

This map shows the geographic impact of David E. Yocum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Yocum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Yocum more than expected).

Fields of papers citing papers by David E. Yocum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Yocum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Yocum. The network helps show where David E. Yocum may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David E. Yocum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David E. Yocum Line = papers co-authored together David E. Yocum links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20145
3 201412
4
The safety and efficacy of infliximab in RA: 1-year results of a large, randomized, placebo-controlled trial in patients with various comorbidities and background treatments as encountered in clinical practice.
20071
5 20076
6 200791
7 2005200
8 200215
9 20024
10
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
Hit paper breakdown →
2000722
11 200010
12 19991
13 1998284
14 199765
15
Rheumatoid Arthritis : The Status and Future of Combination Therapy, Chatham, Massachusetts, USA, July 13-15, 1995
19962
16 199610
17 1995375
18
Legionnaires' disease in a patient with rheumatoid arthritis treated with cyclosporine.
19896
19 198918
20
BCG as active immunotherapy in children with acute lymphoblastic leukemia in longstanding remission: positive effects on remission duration and immunologic parameters.
19782

About David E. Yocum

David E. Yocum is a scholar working on Rheumatology, Immunology, Genetics, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 89 papers that have together received 4.8k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (41 papers), Monoclonal and Polyclonal Antibodies Research (23 papers), Systemic Lupus Erythematosus Research (22 papers), T-cell and B-cell Immunology (17 papers), Chronic Lymphocytic Leukemia Research (11 papers), Autoimmune and Inflammatory Disorders Research (8 papers), Immune Cell Function and Interaction (7 papers) and Toxin Mechanisms and Immunotoxins (6 papers). The work is most often cited by research in Rheumatology (2.4k citations), Ophthalmology (758 citations), Hematology (790 citations), Immunology (1.3k citations) and Genetics (399 citations). David E. Yocum has collaborated with scholars based in United States, United Kingdom and Argentina. Frequent co-authors include James B. Benjamin, Hongbing Wei, Janet L. Funk, Luca Cordaro, R L Wilder, C. Stephen Foster, Scott M. Whitcup, Gary N. Holland, Robert B. Nussenblatt and Douglas A. Jabs. Their work appears in journals such as Seminars in Arthritis and Rheumatism, Immunology, Journal of Clinical Investigation, Rheumatic Disease Clinics of North America and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026